Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cost Of Revenue | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Gross Profit | -8,734 | -8,735 | -8,734 | -8,735 | -2,911 | -- |
| Selling General And Administration | 3.1M | 176,551 | 234,848 | 294,343 | 173,029 | -- |
| General And Administrative Expense | 3.1M | 176,551 | 234,848 | 294,343 | 173,029 | -- |
| Other Operating Expenses | 91,410 | 13,196 | 49,699 | 13,276 | 12,276 | -- |
| Operating Expense | 3.2M | 189,747 | 284,547 | 307,619 | 185,305 | -- |
| Operating Income | -3.2M | -198,482 | -293,281 | -316,354 | -188,216 | -- |
| EBIT | -3.2M | -198,482 | -293,281 | -316,354 | -188,216 | -- |
| Interest Income | 14,114 | 0.00 | 103.00 | 10,795 | 20,175 | -- |
| Interest Income Non Operating | 14,114 | 0.00 | 103.00 | 10,795 | 20,175 | -- |
| Net Interest Income | 14,114 | 0.00 | 103.00 | 10,795 | 20,175 | -- |
| Other Income Expense | -299,883 | 47,906 | 53,884 | -6,339 | 50,897 | -- |
| Special Income Charges | 0.00 | 0.00 | -- | 0.00 | 13,257 | 17,346 |
| Gain On Sale Of Security | -299,883 | 47,906 | 53,884 | -6,339 | 37,640 | -- |
| Pretax Income | -3.5M | -150,576 | -239,294 | -311,898 | -117,144 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Income From Continuing Operation Net Minority Interest | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Income Including Noncontrolling Interests | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Income Common Stockholders | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Income | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| EBITDA | -3.2M | -189,747 | -284,547 | -307,619 | -185,305 | -- |
| Normalized EBITDA | -2.9M | -237,653 | -338,431 | -301,280 | -236,202 | -- |
| Reconciled Depreciation | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Basic EPS | -0.02 | 0.00 | 0.00 | -- | 0.00 | -0.01 |
| Diluted EPS | -0.02 | 0.00 | 0.00 | -- | 0.00 | -0.01 |
| Basic Average Shares | 189.0M | 107.0M | 89.9M | -- | 82.7M | 67.8M |
| Diluted Average Shares | 189.0M | 107.0M | 89.9M | -- | 82.7M | 67.8M |
| Total Unusual Items | -299,883 | 47,906 | 53,884 | -6,339 | 50,897 | -- |
| Total Unusual Items Excluding Goodwill | -299,883 | 47,906 | 53,884 | -6,339 | 50,897 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -3.2M | -198,482 | -293,178 | -305,739 | -185,387 | -- |
| Diluted NI Availto Com Stockholders | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Gain On Sale Of Business | 0.00 | -- | -- | 0.00 | -4,089 | -- |
| Gain On Sale Of Ppe | 0.00 | 0.00 | -- | 0.00 | 17,346 | 17,346 |
| Net Income Continuous Operations | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Non Operating Interest Income Expense | 14,114 | 0.00 | 103.00 | 10,795 | 20,175 | -- |
| Other Gand A | 391,953 | 92,764 | 94,772 | 96,480 | 73,880 | -- |
| Reconciled Cost Of Revenue | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Salaries And Wages | 2.7M | 83,787 | 140,076 | 197,863 | 99,149 | -- |
| Total Expenses | 3.2M | 198,482 | 293,281 | 316,354 | 188,216 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 3.1M | 207,777 | 813,831 | 291,871 | 2.7M | -- |
| Cash Cash Equivalents And Short Term Investments | 3.1M | 207,777 | 813,831 | 291,871 | 2.7M | -- |
| Cash Financial | 3.1M | 207,777 | 813,831 | 291,871 | 2.7M | -- |
| Accounts Receivable | 66,404 | 2,904 | 11,592 | 22,911 | 18,560 | -- |
| Receivables | 66,404 | 2,904 | 11,592 | 22,911 | 18,560 | -- |
| Prepaid Assets | 66,549 | 298,567 | 261,902 | 336,984 | 40,777 | -- |
| Current Assets | 3.3M | 509,248 | 1.1M | 651,766 | 2.8M | -- |
| Gross PPE | 30.7M | 11.4M | 11.0M | 7.9M | 4.6M | -- |
| Accumulated Depreciation | -37,849 | -- | -- | -- | -- | -- |
| Net PPE | 30.7M | 11.4M | 11.0M | 7.9M | 4.6M | -- |
| Other Non Current Assets | -- | -- | -- | -- | -2.00 | -- |
| Total Non Current Assets | 30.7M | 11.4M | 11.0M | 7.9M | 4.6M | -- |
| Total Assets | 33.9M | 11.9M | 12.1M | 8.6M | 7.3M | -- |
| Accounts Payable | 177,551 | 755,077 | 564,460 | 401,347 | 36,388 | -- |
| Payables | 177,551 | 755,077 | 564,460 | 401,347 | 36,388 | -- |
| Payables And Accrued Expenses | 417,057 | 1.6M | 2.4M | 1.5M | 89,979 | -- |
| Current Accrued Expenses | 239,506 | 881,459 | 1.8M | 1.1M | 53,591 | -- |
| Current Liabilities | 417,057 | 1.6M | 2.4M | 1.5M | 89,979 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 417,057 | 1.6M | 2.4M | 1.5M | 89,979 | -- |
| Common Stock | 48.5M | 26.0M | 25.4M | 22.7M | 22.6M | -- |
| Capital Stock | 48.5M | 26.0M | 25.4M | 22.7M | 22.6M | -- |
| Additional Paid In Capital | 4.5M | 1.9M | 1.9M | 1.8M | 1.8M | -- |
| Retained Earnings | -22.9M | -19.4M | -19.3M | -19.0M | -18.7M | -- |
| Common Stock Equity | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Stockholders Equity | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Total Equity Gross Minority Interest | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Total Capitalization | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Net Tangible Assets | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Tangible Book Value | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Working Capital | 2.9M | -1.1M | -1.3M | -854,191 | 2.7M | -- |
| Invested Capital | 33.5M | 10.3M | 9.8M | 7.1M | 7.3M | -- |
| Share Issued | 212.2M | 107.5M | 103.6M | 83.2M | 83.2M | -- |
| Ordinary Shares Number | 212.2M | 107.5M | 103.6M | 83.2M | 83.2M | -- |
| Other Equity Interest | 3.4M | 1.8M | 1.8M | 1.6M | 1.6M | -- |
| Other Properties | 30.7M | 11.4M | 11.0M | 7.9M | 4.6M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.5M | -51,873 | -163,742 | -129,413 | -385,017 | -- |
| Cash Flow From Continuing Operating Activities | -1.5M | -46,873 | -163,742 | -567,839 | -385,017 | -- |
| Depreciation And Amortization | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Depreciation Amortization Depletion | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Stock Based Compensation | 2.5M | 13,787 | 65,076 | 122,863 | 8,884 | -- |
| Change In Working Capital | -566,325 | 81,181 | 1,742 | -387,360 | -266,216 | -- |
| Changes In Account Receivables | -- | -- | -- | -- | -5,277 | -- |
| Change In Receivables | 17,449 | 8,688 | 11,319 | -4,351 | -5,277 | -- |
| Change In Payables And Accrued Expense | -644,861 | 160,617 | 423.00 | 43,865 | -268,803 | -- |
| Capital Expenditure | -1.5M | -1.1M | -2.3M | -2.0M | -591,134 | -- |
| Purchase Of PPE | -- | -- | -- | -6,482 | -- | -- |
| Net PPE Purchase And Sale | -- | -- | -- | -6,287 | -104,813 | -- |
| Purchase Of Business | -- | -- | -- | 0.00 | -- | -- |
| Investing Cash Flow | -1.3M | -1.2M | -2.2M | -2.3M | -591,927 | -- |
| Cash Flow From Continuing Investing Activities | -1.3M | -1.2M | -2.2M | -2.3M | -592,122 | -- |
| Issuance Of Capital Stock | 5.8M | 602,699 | 2.3M | 0.00 | 927,408 | -- |
| Net Common Stock Issuance | 5.8M | 602,699 | 2.3M | 0.00 | 927,408 | -- |
| Financing Cash Flow | 5.7M | 640,699 | 2.9M | -1.00 | 927,408 | -- |
| Cash Flow From Continuing Financing Activities | 5.7M | 640,699 | 2.9M | -1.00 | 927,408 | -- |
| Effect Of Exchange Rate Changes | -- | -- | -- | -- | 0.00 | 0.00 |
| Changes In Cash | 2.9M | -606,054 | 521,960 | -2.4M | -49,536 | -- |
| Beginning Cash Position | 207,777 | 813,831 | 291,871 | 2.7M | 2.8M | -- |
| End Cash Position | 3.1M | 207,777 | 813,831 | 291,871 | 2.7M | -- |
| Free Cash Flow | -3.0M | -1.2M | -2.4M | -2.1M | -976,151 | -- |
| Capital Expenditure Reported | -1.5M | -1.1M | -2.3M | -2.0M | -486,321 | -- |
| Change In Prepaid Assets | 61,087 | -88,124 | -10,000 | -426,874 | 7,864 | -- |
| Common Stock Issuance | 5.8M | 602,699 | 2.3M | 0.00 | 927,408 | -- |
| Depreciation | 8,734 | 8,735 | 8,734 | 8,735 | 2,911 | -- |
| Gain Loss On Sale Of Business | -- | -- | -- | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | 0.00 | -- | -- | 0.00 | 0.00 | -- |
| Net Business Purchase And Sale | -- | -- | -- | 0.00 | -- | -- |
| Net Foreign Currency Exchange Gain Loss | 0.00 | 0.00 | 0.00 | 1.00 | -195.00 | -- |
| Net Income From Continuing Operations | -3.5M | -150,576 | -239,294 | -312,078 | -134,490 | -- |
| Net Other Financing Charges | -- | 38,000 | 120,000 | -- | -- | -- |
| Net Other Investing Changes | -- | -- | 85,082 | -307,954 | 195.00 | -2.6M |
| Operating Gains Losses | -- | -- | -- | 1.00 | 3,894 | -17,346 |
| Proceeds From Stock Option Exercised | 75,000 | 0.00 | 416,958 | -1.00 | 0.00 | -- |
| Sale Of PPE | -- | -- | -- | 195.00 | 0.00 | -- |